Fisher Asset Management LLC lifted its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 64.0% in the third quarter, Holdings Channel reports. The fund owned 100,653 shares of the company’s stock after purchasing an additional 39,268 shares during the quarter. Fisher Asset Management LLC’s holdings in Colgate-Palmolive were worth $8,588,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. raised its holdings in Colgate-Palmolive by 18.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,651,979 shares of the company’s stock valued at $141,843,000 after buying an additional 251,887 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators boosted its stake in Colgate-Palmolive by 9.4% during the third quarter. PBU The Pension Fund of Early Childhood & Youth Educators now owns 137,415 shares of the company’s stock worth $11,724,000 after buying an additional 11,824 shares during the period. Three Bridge Wealth Advisors LLC purchased a new position in Colgate-Palmolive during the third quarter worth $131,000. Maryland State Retirement & Pension System boosted its stake in Colgate-Palmolive by 13.4% during the third quarter. Maryland State Retirement & Pension System now owns 48,672 shares of the company’s stock worth $4,153,000 after buying an additional 5,756 shares during the period. Finally, Ritholtz Wealth Management increased its position in Colgate-Palmolive by 16.1% during the third quarter. Ritholtz Wealth Management now owns 71,381 shares of the company’s stock valued at $6,090,000 after acquiring an additional 9,881 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have recently weighed in on CL. Royal Bank Of Canada increased their target price on shares of Colgate-Palmolive from $104.00 to $105.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating for the company in a report on Monday, November 2nd. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $95.00 and gave the stock an “equal weight” rating in a research note on Monday, November 2nd. BNP Paribas Exane reiterated an “outperform” rating and set a $108.00 price target (up from $97.00) on shares of Colgate-Palmolive in a report on Monday, November 2nd. Finally, Morgan Stanley increased their price objective on shares of Colgate-Palmolive from $104.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, November 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.22.
Check Out Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive News Summary
Investors following CL have been watching these news items:
- Positive Sentiment: A valuation analysis argues that Colgate-Palmolive shares may be about 21% below fair value, which could support investor interest if the estimate proves accurate. Colgate Palmolive (CL) Stock May Be 21% Below Fair Value Today
- Neutral Sentiment: The estimate changes were mixed: Zacks raised some quarterly forecasts but lowered others, including Q1 2027 and Q1–Q2 2028. That tempers the positive full-year revisions and does not indicate a broad upgrade to near-term expectations. Zacks Research quarterly earnings estimate revisions
- Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company stock. Insider sales can weigh on sentiment, although a single transaction does not necessarily signal a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells $401,677.00 in Stock
Insider Activity at Colgate-Palmolive
In related news, EVP Gregory Malcolm sold 4,100 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $97.97, for a total value of $401,677.00. Following the transaction, the executive vice president owned 10,061 shares of the company’s stock, valued at $985,676.17. This trade represents a 28.95% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 19,938 shares of Colgate-Palmolive stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the sale, the chief operating officer owned 9,111 shares of the company’s stock, valued at $899,620.14. The trade was a 68.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 77,414 shares of company stock valued at $7,613,786 over the last ninety days. Company insiders own 0.43% of the company’s stock.
Colgate-Palmolive Price Performance
CL opened at $99.62 on Monday. The business has a fifty day moving average of $90.94 and a 200 day moving average of $90.29. Colgate-Palmolive Company has a 52-week low of $75.96 and a 52-week high of $101.18. The company has a quick ratio of 0.63, a current ratio of 0.96 and a debt-to-equity ratio of 11.23. The stock has a market cap of $79.19 billion, a P/E ratio of 39.07, a PEG ratio of 4.51 and a beta of 0.31.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter in the prior year, the company posted $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.92 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th were paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, October 20th. Colgate-Palmolive’s payout ratio is currently 83.14%.
Colgate-Palmolive Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Read More
- Five stocks we like better than Colgate-Palmolive
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
